# NAVITRUX
> **NDA220436** · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2026-06-24
## Drug
- **FDA Application Number:** NDA220436
- **Application type:** New Drug Application
- **Brand name:** NAVITRUX
- **Generic name:** FOSAPREPITANT
- **Active ingredients:** FOSAPREPITANT DIMEGLUMINE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AVYXA HOLDINGS
- **Manufacturer:** AVYXA Pharma, LLC
- **First approval:** 2026-06-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220436)
---
*MORVS · CC0 1.0*